​Cannabis Producer, Sundial Growers, Files to List on NASDAQ

Stephen L Kanaval  |

Following the path laid out by Tilray  (TLRY), private company Sundial Growers filed documents to list on the Nasdaq Global Select Market under ticker symbol SNDL. Cowen, BMO Capital Markets and Barclays are joint-leading the initial public offering, and the company's Form F-1 shows a proposed $100 million raise.

Sundial is a cannabis cultivator with agreements with five provincial regulators and will soon be entering the global CBD space following the acquisition of Bridge Farm, a company based in the United Kingdom. Collectively the firm currently has 60,000 KG of licensed capacity within the country, but the figure will be closer to 95,000 upon the final completion of facilities in Olds, Alberta, and Merritt, British Columbia.

According to the preliminary prospectus, Sundial generated net revenue of C$1.5 million in Q1 and the company reported pro forma cash of C$29 million. Bridge Farm generated C$20.4 million over the last ten months. The operation currently has a license to grow hemp indoors at its Spalding facility, which currently consists of 40,000 square feet.

"This is a significant acquisition for Sundial, taking us one step closer to our goal of being one of the leading cannabis companies in the world," said Torsten Kuenzlen, Chief Executive Officer of Sundial, in the company press release. "We recognize that expedient global expansion requires a combination of organic growth and strategic acquisitions. Bridge Farm's experienced management team, strong market position and operational excellence made it an ideal acquisition."

Bridge Farm will also transition to growing cannabis pending regulatory approval, according to the prospectus. Clearly, one of the key advantages in purchasing Bridge Farms was that it gave Sundial immediate topline revenues. In addition, the facility in Spalding will expand to 3.8 million square-feet making it one of the largest fully-automated growing structures in Europe giving Sundial the chance to be one of the first movers at scale within the CBD wellness market.

"I am excited and confident that Sundial will continue to improve the operational excellence and the quality of the products grown in the Bridge Farm facilities," said David Ball, Sundial's President, Europe, in the same release. "There is a local, European and global demand for CBD and other cannabis products, which we are well positioned to supply. Sundial is poised to become a leader in the Help sector."

The Calgary company was founded in 2006 and is known for three categories of products “Heal”, “Help” and “Play.” As stated above, Sundial is following the same path to market as Tilray who listed shares at $17 on Nasdaq and they are now trading above $45. Of course, Cronos Group Inc. was the first Canadian pot company to list on a U.S. Exchange, but its shares were already trading in Canada.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CRON Cronos Group Inc. 14.99 0.05 0.33 2,793,089 Trade
TLRY Tilray Inc. 44.25 -0.16 -0.36 972,867 Trade

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Jorge Fernandez - iBlades

Equities.com's Sam Mitchell interview iBlades CEO, Jorge Fernandez